Women who are obese face an increased risk of developing an aggressive sub-type of breast cancer known as 'basal-like', scientists, including one of Indian-origin, have found.
Researchers at the University of North Carolina found that obesity radically alters the cellular microenvironment of mammary glands in ways favourable to the growth of basal-like tumours.
The basal-like subtype, an aggressive form of breast cancer, is found in 15 to 20 per cent of women diagnosed with breast cancer, with a high percentage of cases found among young and African-American women.
Women diagnosed with the basal-like subtype often have a poor prognosis and cannot be treated with hormonal and targeted therapies.
A team led by Liza Makowski, assistant professor with the UNC Gillings School of Global Public Health and member of the UNC Lineberger Comprehensive Cancer Center, and Sneha Sundaram, a post-doctoral fellow in the Makowski Lab, outlined the biological mechanisms where obesity can create a favourable environment for the growth of basal-like breast cancer tumours.
"Obesity is widespread and is one of the few risk factors for breast cancer that we may be able to control, hence our intention in this study was to better understand the molecular mechanisms and/or biomarkers of obesity-related basal like breast cancer that could impact disease prevention," said Makowski.
Using a mouse model developed to study the basal-like subtype, the research team found that obesity promotes a growth factor signalling pathway between the hepatocyte growth factor (HGF) protein and an oncogene known as c-Met that is linked with basal-like cancer formation.
In animals with elevated levels of HGF, the development of basal-like tumours increased.
"Our study was fairly unique in that we focused on the role that the surrounding tissue in the breast, known as the stroma, plays in breast cancer onset. Many scientists study the tumour alone, but the stroma 'soil' where the cancer 'seed' grows is important in helping that tumour grow," said Makowski.
Since HGF levels are increased with obesity, the study indicates that public health efforts to prevent obesity in at-risk populations may be a clinically useful way of preventing the disease.
Makowski said that whether weight loss can minimise breast cancer risk in already obese patients is an area that needs further investigation.
The study was published in the journal Breast Cancer Research and Treatment.
